GGrantIndex
Sort

78,016 grants matching breast cancer

Tissue mechanics reprograms the tissue to malignancy and metastasis

$969,000
Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2020 · CA

Tissue mechanics reprograms the tissue to malignancy and metastasis

$969,000
Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2021 · CA

High-speed panoramic 3D photoacoustic computed tomography of the breast

$968,810
Lihong Wang · California Institute Of Technology · R35 · FY2021 · CA

Homology-directed repair: BRCA2 and RAD51 paralogs

$968,795
Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA

Understanding and Addressing Cancer Health Disparities in Louisiana

$968,492
Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2020 · CA

CANCER AND INFLAMMATION GENETICS

$968,200
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

CANCER AND INFLAMMATION: FUNCTION AND THERAPY

$968,200
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Breast Cancer Sister Study

$968,118
Johns Hopkins University · N01 · FY2012 · ES

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

$967,979
Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2022 · CA

Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level

$967,866
Andrea Califano · Columbia University Health Sciences · U01 · FY2025 · CA

Biomarker and Phenotypic Risk Factors for Breast Cancer Lymphedema

$967,755
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2015 · CA

Hormone Receptors and Genes Regulating Gonadal and mammary function

$967,347
Maria Dufau · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD

High-throughput immunoproteomics for cancer biomarker discovery

$967,342
Joshua Labaer · Arizona State University-Tempe Campus · U2C · FY2025 · CA

Occupational Exposure Assessment

$967,268
Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial

$967,232
Joerg Herrmann · Mayo Clinic Rochester · R01 · FY2020 · CA

Biostatistics Resource

$967,148
Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2009 · CA

ACCESS-PC: Advancing Care Coordination to Enhance Shared Care for Complex Survivors in Primary Care

$967,120
Denalee M. O'Malley · Rutgers Biomedical And Health Sciences · U01 · FY2025 · CA

ACCESS-PC: Advancing Care Coordination to Enhance Shared Care for Complex Survivors in Primary Care

$967,120
Denalee M. O'Malley · Rutgers Biomedical And Health Sciences · U01 · FY2024 · CA

Functional Analysis of Human Breast Cancer Susceptibility Gene Variants

$966,864
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

THERAPEUTIC REACTIVATION OF THE PP2A TUMOR SUPPRESSOR FOR BREAST CANCER TREATMENT

$966,850
Regents Of The University Of Michigan · · FY2020 · Defense Health Agency

UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM

$966,615
Spartanburg Regional Medical Center · U10 · FY2000 · CA

The role of the ATM gene in familial breast cancer

$966,568
Georgia Chenevix-Trench · Queensland Institute Of Medical Research · R01 · FY2006 · CA

MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM

$966,492
Balazs Halmos · Montefiore Medical Center (Bronx, Ny) · UG1 · FY2022 · CA

Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development

$966,420
John David O'Neill · Xylyx Bio, Inc. · R44 · FY2025 · CA

Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins

$966,178
Weidong Wang · National Institute On Aging · ZIA · FY2019 · AG